Hikma to present at 37th Annual J.P. Morgan Healthcare Conference

London, 3 January 2019 – Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1 Moody’s / BB+ S&P, both stable) today announces that Siggi Olafsson, Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 8, 2019 at 8.30am Pacific Standard Time (4.30pm GMT).

Press Release Corporate 3 January 2019

A live audio webcast of the presentation will be available on the Investors section of Hikma‚Äôs website at https://www.hikma.com/investors/results-reports-and-presentations/#page=1.  A replay of the website will be available for approximately 90 days.

 

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.